Stem cells are capable of extensive self-renewal in the absence of differentiation. The maintenance of this undifferentiated state occurs despite the fact that this cell is exposed t o a milieu that is rich in a variety of growth and differentiation factors. A unifying feature of such hematopoietic factors is that they mediate their effects through the phosphorylation of tyrosine residues by various cellular kinases. Therefore, one mechanism that might inhibit such differentiation signals in the self-renewing stem cell is the dephosphorylation of tyrosine residues by protein tyrosine phosphatases (PTPs). We have thus investigated the types of tyrosine phosphatases expressed by murine embryonic lin'°CD34hiS-CBhi hematopoietic progenitor cells by using a consensus polymerase chain reaction (PCR) approach. Although many known tyrosine phosphatases were detected using this method, a novel PTP related to the previously described PTP PEST type enzymes, murine PTP PEP and murine/human PTP PEST, was also observed. Cloning of the full-length cDNA encoding this enzyme showed that it was indeed a novel new member of this family, with an amino terminal tyrosine phosphatase domain followed by a region rich in HE ABILITY OF THE hematopoietic stem cell to function as a source of committed progenitors throughout the lifetime of the organism is, at present, a poorly understood phenomenon. The major characteristic of the hematopoietic stem cell (HSC) is its ability to self-renew in the absence of differentiation.' This self-renewal phenomenon is especially remarkable in light of the fact that the hematopoietic stroma, which is in close physical contact with the stem cell, is known to be a source that is rich in factors that mediate the growth and differentiation of hematopoietic progenitors.* For example, a recent polymerase chain reaction (PCR) analysis of hematopoietically active endothelial cell stromal lines derived from the murine yolk sac showed that these cells produced a plethora of growth and differentiation factors, including stem cell factor, FLT 3 ligand, macrophage colony-stimulating factor (M-CSF), leukocyte-inhibitory factor (LIF), and interleukin-6 (IL-6).3 Such growth factors, in addition to many others, are known to induce the expansion and differentiation of stem cells, and these endothelial lines induced a rapid expansion and differentiation of embryonic HSCs along the myeloid pathway. It has also been clearly shown that incubation of highly purified 0 1996 by The American Sociely of Hematology. 0006-4971/96/8804-07$3.00/0 1156 serine, threonine, and proline. The carboxy terminus of this novel PTP contained a short sequence that was homologous t o a region of the murine PTP PEP that was involved with nuclear localization. Bacterial expression of the phosphatase domain showed that this enzyme could efficiently dephosphorylate tyrosines in vitro. Analysis of the expression of the novel nuclear PTP by quantitative PCR showed that the transcript disappeared as the lin'°CD34h'Scah' cells differentiated in the presence of interleukin-l, interleukin-3, erythropoietin, and granulocyte-macrophage colony-stimulating factor. In agreement with its potential role in the hematopoietic progenitor cell, this novel PTP was expressed at a barely detectable level in a very limited subset of adult tissues. However, analysis of several murine hematopoietic progenitor cell lines, but not of a differentiated T-cell line, showed a high level of expression of the novel PTP. These data suggest that this novel phosphatase may play a critical role in the maintenance of the undifferentiated state of the hematopoietic stem cell. stem cell populations in the presence of various purified hematopoietic growth factors induces differentiation with subsequent loss of the cells ability to competitively repopulate the hematopoietic compartment of lethally irradiated animals, consistent with the induction of terminal differentiat i~n .~ Thus, the stem cell, whether in an embryonic or adult stromal environment, must maintain an undifferentiated state despite the fact that it is being exposed to a variety of such maturation factors. ' A unifying aspect of the hematopoietic growth factors is their role in mediating protein phosphorylation.5 This protein modification can occur via direct means, such as in the cases of the stem cell factor and FLT 3 receptors, both of which have intrinsic tyrosine kinase activity, or via indirect means, as is the case of the hematopoietic/cytokine growth factor receptors for, eg, IL-3, erythropoietin (EPO), and thrombopoietin (TPO). In the case of the hematopoietic/cytokine growth factor receptors, tyrosine phosphorylation is indirectly accomplished by the activation of the JAK kinases, which occurs after growth factor-mediated receptor dimerization.' In both cases, diverse complex pathways of protein phosphorylation are stimulated upon receptor binding. The intrinsic tyrosine kinase receptors mediate their signals via an elaborate series of tyrosine phosphorylation events that ultimately activate the RAS signaling p a t h~a y .~ This pathway eventually leads to the activation of the serinelthreonine-specific MAP kinase pathway, which results in transcriptional activation. In contrast to this intricate pathway, hematopoietic growth factor-induced receptor dimerization mediates more direct activation events. Thus, the stimulation of the JAK kinases by receptor binding leads to the tyrosine phosphorylation and subsequent dimerization of various STAT proteins. These activated STAT proteins than migrate to the nucleus, bind to STAT responsive sites in the nuclear
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The regulation of protein tyrosine phosphorylation is accomplished by a balance between protein tyrosine kinases and protein tyrosine phosphatases (PTPs).',~ All PTPs contain a phosphatase domain including a subset of highly conserved amino acids, and a recent crystal structure analysis of PTP 1B complexed with a tyrosine phosphorylated peptide showed that many of these conserved residues are involved with substrate recognition and tyrosine dephosphorylation." PTPs fall into two general categories: receptor type and nonreceptor type. The receptor-type PTPs have variously sized extracellular domains and, generally, two intracellular phosphatase
The extracellular domains often contain a number of motifs that are generally used in cell adhesion, including Ig domains and fibronectin-like regions. Many of these PTPs appear to function as homotypic and heterotypic sensors of the extracellular space, and they have been hypothesized to play roles in contact inhibition, cell guidance, and other intercellular functions." The nonreceptor PTPs are generally intracellular enzymes. They have various cellular localizations, depending on the types of domains they contain, and some of the enzymes contain SH2 motifs that allow them to interact intimately with phosphotyrosine residues. Although many of the nonreceptor PTPs are in various cytoplasmic locations, a small number of these enzymes are found in the nucleus.'' Many nonreceptor PTPs appear to function as both activators and inhibiters of diverse tyrosinephosphorylated proteins. A subset appears to play important roles in hematopoiesis. For example, the motheaten mouse, which has a phenotype of lethal myeloid amplification and inflammation, has been found to have a mutation in the PTP 1C gene. '3,'4 In addition, the level of tyrosine phosphorylation of the EPO receptor and the level of receptor activation appear to be controlled, in part, by the PTP 1C enzyme as well." However, although these examples, as well as others, highlight the potential importance of the PTPs, very little is known regarding the physiologic importance of these enzymes.
One mechanism by which the undifferentiated state of the stem cell might be maintained is the dephosphorylation of tyrosine-phosphorylated proteins by FTPs. To examine this possibility, we have analyzed a large number of PTPs from a very primitive embryonic hematopoietic cell population using consensus PCR. From this population, we have cloned a novel PTP that has many of the characteristics, including downregulation of the transcript as the HSCs differentiate, that might be expected from a PTP involved with the control of differentiation signals such as those induced by hematopoietic growth factors.
MATERIALS AND METHODS
Isolation of embryonic lin'"CD34h'Scahi HSCs. Yolk sacs or embryos were dissected from timed pregnant females at day 10.5. Fetal livers were isolated from day-13.5 to -14 embryos. Yolk sac and embryonic tissues were dissociated with 1% collagenase in RPM1 medium at 37°C for 15 minutes. Cells were further dissociated by two passages through a 16-guage needle. Fetal liver was only dissociated by passage through a 16-guage needle. Adherent cells were attached to plastic by overnight incubation, after which the nonadherent hematopoietic cells were incubated with a lineage-specific cocktail of antibodies (1 pg each of TER 119, Gr-l, Ly-l, transfemn receptor, and B220) for 1 hour on ice. Cells were washed, and the lineage-positive cells were depleted using magnetic beads and a Miltenyi column. Lineage-negative cells were pelleted, resuspended in 2% fetal calf serum (FCS) and phosphate-buffered saline (PBS), and incubated with rabbit antimurine CD34 antibody16 on ice for 1 hour. Cells were washed three times in 2% FCS and PBS, resus- and Moloney murine leukemia virus revere transcriptase (SuperScript 11; GIBCO BRL, Gaithersburg, MD). One fourth of this cDNA was amplified by PCR using degenerate mixed oligonucleotides primers. Sense and antisense primers corresponding to the consensus PTP amino acid sequences H/DFWR"/vW (5'-AC/Tm/TTGGA/cGI-ATGA/,TITGG-3') and WPDF/,GVP (5'-GGIACGIAT/AG/A"/ATCI-GGCCA-3'), respectively, were used. PCR assays were performed in 1 X Taq DNA polymerase buffer (GIBCO BRL) plus 0.2 mmol/ L of each dNTP, 10% dimethylsulfoxide (DMSO), and 5 U Taq polymerase (GIBCO BRL) for 25 cycles of 94°C for 1 minute, 55°C for 1 minute, and 72°C for 1 minute. The PCR products were treated with Klenow enzyme (New England Biolabs, Beverley, MA) at 30°C for 30 minutes, cloned into the Sma I site of the pRK-5 plasmid, and subsequently sequenced (Sequenase; US Biochemicals, Cleveland, OH).
cDNA and genomic cloning. Adapter-linked double-strain cDNA was prepared from A+ RNA of day-l0 murine embryos (Marathon-Ready cDNA synthesis kit; Clontech, Palo Alto, CA) using either random hexamer or oligo dT primer. Full-length cDNA was isolated by 5' or 3' rapid amplification of cDNA ends (RACE) of the cDNAs.
Genomic clones encoding the PTP HSC fraction (HSCF) gene were isolated using standard techniques. The plaque-purified A phage DNA was digested with Not I, and the insert fragment was directly cloned without purification into Nor I-digested Bluescript. Exons were mapped using a combination of restriction digestion and Southem blotting as well as DNA sequencing using custom primers.
Bacterial expression of the PTP. cDNA sequences encode amino acid 8 to 323 containing the phosphatase domain were obtained by PCR using sense oligomer 5'-CACGGTCGACGGTGAGGAGCT-TCTITGAGCAGCTGGAGG-3' and antisense oligomer 5'-GTT-3'. The PCR fragment was treated with Sal I and Not I restriction enzyme and cloned into Sal I-and Not I-digested pGEX-4T-I plasmid (Pharmacia). The fusion protein was affinity-purified using a glutathione sepharose column (Pharmacia). A GST-fusion containing CyszZ9-Ser active site mutant was constructed by PCR mutagenesis. Both the wild-type and mutant forms of the enzymes were identical in size on sodium dodecyl sulfate (SDS) polyacrylamide gels. Tyrosine phosphatase assays on the glutathione S transferase (GST)-fusion proteins were performed following the manufacture's procedure using two different tyrosine-phosphorylated peptides from Quantitative PCR analysis of RNA isolatrd frotn Iwrtzutopoietic c d l s . Lin'"CD34h'Sca'" hematopoietic progenitor cells were puritied from fetal livers using fluorescence-activated cell sorting (FACS).',I7 Briefly, the fetal livers of day-14 to -15 murine e1nbryo.s were disrupted by passage through a 16-guage needle, and the lineage-positive cells were depleted using a cocktail of MoAbs against various mature hematopoietic cell markers and magnetic bead separation. The h ' " cells were then incubated with polyclonal antimurine CD34 antibody' and a monoclonal against Sca I (Pharmingen).' The CD34h'Scah' and CD34h'Sca'" fractions were isolated using FACS. Reexamination of these purified cells by FACS showed that they were 9S% to 98% pure, and analysis of the cells by WrightGiemsa staining showed that all cells appeared to he blast-like hematopoietic progenitor cells. cDNA was made from A' RNA by reverse transcription (RT) with random hexamer. PCR was then used to amplify quantitatively PTP HSCF cDNA and. as an internal standard, triosephosphate isomerase (TPI) cDNA. TPI is a housekeeping gene that is used routinely as an internal standard for quantitative PCR experiments because its level is constant between a diversity of cell types. For each PCR, 6 pL of the 20 pL RT reaction was brought to SO p L so as to contain 0.3 mmol/L of dNTPs, 4-pCi of "P dATP (3,000 Ci/mmol; Amersham, Arlington Heights, IL), 1 0 0 pmol of each of the four primers, and S U of Taq DNA polymerase (GIBCO BRL). Seventeen PCR cycles of 94°C for SO seconds. S S T Tor SO seconds, and 70°C for 70 seconds were performed. One-tenth of each PCR sample was electrophoresed in a 6% polyacryla~nide gel, and the PCR products were quantitate by phosphorimaging (Fuji Imaging Group, Groton, CT). Conditions for accurate quantitation of either the novel PTP or TPI were assessed in experiments that used serial dilutions of a standard preparation of A' RNA from 32D cells to determine for each primer pair the times of primer annealing and primer extension and the cycles that provided for a linear correlation between the amount of template RNA and the PCR product. Under the PCR conditions ultimately chosen. a certain amount of sample RNA was analyzed simultaneously with serial dilutions of the standard RNA and a reverse transcriptase minus control.
GCGGCCGCGATTGGAGCGCAGTTCTCCTGGAGGTTCTGG-
Northern blot unu1y. antisense primer, S'-GAATGGTAACCTGGAGGGTCCTGAG-3'.
TPI: sense primer, S'-GAGAAGGTCGTGTTCGAG; antisense primer, S'WTGTACTTCCTGTGCCTG-3'.
RESULTS

cDNA cloning c$ PTPs from HSCF.
To analyze PTPs potentially involved with the maintenance of the HSC, we isolated a highly purified population of these cells from either the murine 10.5-day yolk sac or embryo. Previously, we showed that both progenitor activity as well as stromal cell repopulating activity were found in the CD34h' fraction of' these embryonic cells' (C. Fennie and L. Lasky, unpublished observations). In addition, others have shown that the murine CD34h' population isolated from bone marrow" or fetal liver'" contains stem cells capable of reconstituting lethally irradiated animals. To isolate a more highly purified fraction of these progenitor cells, we included a lineage-depletion step in addition to the CD34 antibody. These morphologically primitive hematopoietic cells show a higher degree of stromal cell repopulating ability as well as cobblestone formation as compared with the previously described CD34h' progenitor cells, and we are currently investigating their in vivo repopulating activity (C. Fennie and L. Lasky, unpublished observations). Previous investigators have shown that the lin'"CD34'" fraction of bone marrow hematopoietic cells has a high level of repopulating activity.lx Thus, it is likely that the lin'"CD34h' cells isolated from the early embryo contain self-renewing HSCS.''-*~ Consensus PCR using primers derived from two highly conserved regions of the PTP phosphatase domain resulted in the cloning and sequencing of -70 PCR fragments. As shown in Table 1 , a diverse number of known receptor and nunreceptor PTPs were detected in this fraction of these progenitor cells, and many of these PTPs have not previously been described in the HSC compartment. Two novel PTPs (referred to in Table 1 as PTP 38 and PTP 49) were also For personal use only. on October 31, 2017. by guest www.bloodjournal.org From isolated. One is a receptor PTP that is related to the homotypically interacting p, K , and LAR family and will be the subject of a subsequent report (J. Cheng and L. Lasky, unpublished data, December 1995). In brief, this receptor-like PTP is found to be a broadly expressed enzyme with particularly interesting expression in the epithelial cells of the lung and kidney and in various neuronal populations in the developing and neonatal brain. The second PTP was found to be most homologous to two previously described nonreceptor PTPs, murine PTP PEPz1 and murinehuman PTP PEST,22-24 both of which contain a region that is very high in proline, glutamate, serine, and threonine (the PEST domain). One of these PTPs, PEP, has been demonstrated to be localized to the nucleus" (see below); therefore, it appeared that the novel PTP fragment may have been a new member of this potentially nuclear-localized PTP family.
Initial PCR and Northern analyses with the PTP fragment showed that the transcript encoding this enzyme is extremely rare in embryonic and adult tissues. Thus, the full-length cDNA was cloned using the RACE procedure and RNA isolated from day-l0 embryos. Because the RACE cloning of the 5' region was particularly difficult, the final 5' sequence was confirmed using the genomic clone encoding this PTP. As can be seen in Fig 1, this transcript encodes an open reading frame of 453 amino acids specifying a protein of molecular weight 50,253 daltons. Sequence similarity searches showed that the region encoding amino acids 25 to 290 was highly homologous to a variety of PTPs, with the highest degree of sequence similarity with murine PTP PEP" and murineihuman PTP (Fig 2) . Interestingly, PTP PEP has also been found to be expressed in mature hematopoietic cells,"." although human and murine PTP PEST appear to have a more generalized expression att tern.'^.^^ As has been shown in these two previously described PTPs, the novel PTP reported here contains a region 3' of the PTP domain that is very rich in proline, serine, and threonine (-29%; boxed residues in Fig 1) . This region lacks other significant sequence similarity with PTPs PEP and PEST, and it is also much shorter in the novel PTP described here. Finally, a short region of 20 amino acids at the very carboxy terminus of the protein is highly homologous to similar carboxy-terminal regions in PTPs PEP and PEST (Fig 2) . This region is rich in basic residues and the homologous area in PTP PEP has been shown to be involved with the localization of this enzyme to the nucleus.'* However, this region also contains two negatively charged residues (arrowheads in Fig  2) , so it is likely that this novel PTP is a cytoplasmically localized enzyme, as has been shown for PTP PEST.24 Finally, the novel PTP described here contains a serine residue at position 37 (shown starred in Fig 2) that is conserved in all three members of this family and that has been shown to be phosphorylated in PTP PEST by protein kinases C and A.25 Interestingly, increased phosphorylation at this site is inhibitory to the PTPase activity of this PTP.25 In summary, the novel PTP described here appears to be a new member of a family of nonreceptor PTPs that contain P-, S-, and Trich, regions (Fig 3) . In addition, all three of these PTPs contain a homologous carboxy-terminal region that has been shown to function as a nuclear localization signal for one of the family members (PTP PEP), although the murine PEST enzyme has been found to localize to the cytoplasm. Although this novel PTP is expressed at low levels in at least two nonhematopoietic sites (see below), because it was isolated from a fraction of hematopoietic cells that includes stem cells capable of reconstituting the bone marrow of lethally irradiated animal~,l**'~ (C. Fennie and L. Lasky, unpublished data, April 1996), we will heretofore refer to this novel PTP as PTP HSCF.
Previous analyses of the genomic structures of other PTPs suggested that these enzymes were constructed from genes containing a large number of introns. This appears to be the case for the novel PTP described here as well. As can be seen from Fig 4, Although the sequence of the N-terminal PTP domain contained many of the conserved amino acids found to be critical for substrate recognition and tyrosine dephosphorylation," it was important to show that this sequence indeed encoded an active PTP domain. To this end, we produced a construct using the GST fusion system that contained the entire PTP-homologous region derived from the novel cDNA clone. The protein was isolated from induced cultures of bacteria, and it was tested for the dephosphorylation of tyrosine using two different phosphorylated peptides (see the Materials and Methods). As can be seen in Fig 5, the isolated GST-PTP domain fusion protein had a significant level of PTP activity, with dephosphorylation of a tyrosine phosphorylated peptide occuring at only 20 pg of enzyme per reaction. Figure 5 also shows that this activity was completely sensitive to orthovanadate, a specific inhibitor of tyrosine phosphatase~.'.~ Finally, Fig 5 also shows that mutation of Cys229r the residue that is homologous to the active site Cys in all other tyrosine phosphatase^,',^ to serine results in an inactive enzyme. These data thus indicate that this hematopoietic progenitor cell PTP is an active tyrosine phosphatase.
Expression of the progenitor cell PTP transcript. The isolation of the novel PTP from the lin'°CD34hi population of HSCs suggested that this PTP might be specific for very early progenitor cells. To examine this possibility, we analyzed the levels of this enzyme in the lin'"CD34h'scah' fraction, a largely undifferentiated population containing hematopoietic stem cell^,'^^'^^*^ versus the lin'°CD34h'scaio population, a more differentiated cell population containing committed progenitor^.'^ Figure 6A shows that these populations were highly purified, and the Wright-Giemsa analysis shown in Fig 7A illustrates 
CGAGTGCTGT GCCAGTTATA GCCTGCCACT CGGTGGTGGC TGGACTCCTG GAACCACCAT ACTGCTGTGC AGTGTGTTAT GTATGAGTGG GACTTGTGGG CCTGATTCAA AATAAAAGTT TCTCAGGGCA GAAAAAAAAA AAAAAAAAA The phosphatase domain homologies show that these three proteins are highly related t o each other. A star over the residue (amino acid 37 of PTP HSCF) shows a conserved serine that is phosphorylated by protein kinases A and C and that appears t o negatively regulate PTPase activity.*' A second highly homologous region is found at the carboxy terminus of these three proteins. This region has been shown t o confer nuclear localization on PTP PEP. Interestingly, PTP PEST is localized to the cytoplasm, and it has been hypothesized that this is due to the two negatively charged residues shown by the arrows. As can be seen, PTP HSCF also contains these negatively charged residues, suggesting that it is also localized t o t h e cytoplasm. progenitor cells with no obvious evidence of any contaminating cell types. As Fig 6B shows , quantitative PCR comparing the levels of the transcript encoding the novel PTP in the linl"CD34'"scah' versus the lin'"CD34'"scal" population showed that there was an approximately IO-fold lower level of the transcript in the more differentiated sca'" cells. These data are consistent with a downregulation of the PTP HSCF as the lin'"CD34'"scah' stem cell population differentiates into the more committed lin'"CD34"'scal" progenitor cells, and they concur with the lack of detectable Northern signals obtained from the spleen, a site that contains mature hematopoietic cells (see below). In addition, they support the notion that PTP HSCF is derived from hematopoietic cells rather than contaminating nonhematopoietic cells, because it is highly unlikely that any contaminating cells would have the same lin'"CD34h'sca"' surface phenotype as the HSCs. It would therefore be expected that the level of this enzyme would be higher in the linl"CD34'"scal" population if this transcript was derived from a contaminating cell type.
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To examine if this downregulation continued as differentiation progressed, quantitative PCR was performed using RNA isolated from suspension cultures of lin'"CD34h'scah' cells that were exposed to IL-l, IL-3, EPO, and granulocytemacrophage colony-stimulating factor (GM-CSF) for various periods of time in the absence of stromal cells. Figure 7A shows that the purified lin'"CD34h'scah' cells, which initially appeared as undifferentiated blast-like cells, expanded dramatically under these conditions, and Wright-Giemsa analysis of these expanded cells showed that they differentiated eventually to become predominantly macrophages. As Fig  7B shows , the transcript encoding the novel PTP disappears as the cells replicate and develop, and it is completely absent after approximately 7 days in culture. These data are again consistent with a role for this PTP in early stem or progenitor cells, but not in the mature, committed cell populations.
The potential importance of this PTP specifically to the hematopoietic system is shown in Fig 8A, in which Northern blot analyses of various tissues and cell lines are shown. As can be seen from Fig 8A , the transcript appears to be undetectable in the embryonic samples, and it is expressed at exceedingly low levels in adult lung and kidney. Thus, although there are clearly HSCs in the embryo, they must be so rare as to not allow for the direct detection of the transcript encoding the novel PTP. This result also supports the contention that this novel PTP is derived from HSCs and not from a contaminating cell type. Particularly interesting is the lack of a signal encoding the full-length (-1.8 kb) transcript in RNA isolated from the adult spleen, a hematopoietic compartment that contains predominately mature, differentiated hematopoietic cells and that was previously shown to express PTP PEP." This latter results supports the loss of the PTP HSCF transcript observed during the in vitro differentiation of the lin'"CD34h'scah' progenitor cells. The very faint transcripts detected in the lung have been confirmed by nonquantitative PCR analysis (J. Cheng and L. Lasky, unpublished data, December 1995). However, the transcripts in the lung are very rare and may be aberrant, because screening of an adult lung library (l X 1 Oh clones) resulted in only two positive isolates, both of which contained introns (J. Cheng and L. Lasky, unpublished observations).
The lack of detectable signal in most tissues of the adult and embryo, coupled with the identification of the transcript in the highly purified stem cell population, but not in the For As Fig 8B shows , the transcripts encoding this novel PTP are easily detectable in the three different murine hematopoietic progenitor cell lines tested by both Northern and PCR analyses. In all three cases, these lines represent relatively undifferentiated precursors of mature hematopoietic cells, although they are certainly not self-renewing stem cells. The cells appear to encode two major transcripts, in addition to a diversity of minor transcripts. One major transcript is an -1.8-kb RNA that corresponds to the cDNA clone described above, whereas the other encodes an -0.7-kb RNA that remains to be characterized. However, it is likely that this smaller transcript is due to alternative splicing, because, as described above, the gene encoding this PTP is divided into a large number of exons (Fig 4) . Figure 8C shows that the novel PTP transcript is undetectable by PCR in a differentiated T-cell clone, a result that is again consistent with the downregulation of this PTP in differentiated hematopoietic cells. Finally, PCR analysis of various human cell lines using the murine primer pair showed expression of a similarly sized fragment in human CMK progenitor cells, and the sequence of this PCR fragment showed that the human homologue is highly conserved with the murine PTP (Cheng et al. unpublished results, February 1996) . In summary, the novel PTP described here appears to be expressed predominately in very early hematopoietic progenitor cells, consistent with a potential role in the regulation of the differentiation state of these cells.
DISCUSSION
The ability of the HSC to self-renew in the absence of differentiation is an important factor that allows for this cell to provide a large number of progeny throughout the lifetime of the organism. The maintenance of the undifferentiated state must occur at the same time as the stem cell replicates, because this cell type must be continually replenished. Thus, there must be specific mechanisms that decrease some aspects of cellular activation, such as differentiation, while not affecting others, such as division. Because tyrosine phosphorylation is a critical aspect of cellular activation, it is likely that distinctive mechanisms that regulate tyrosine phosphorylation are involved with the maintenance of the self-renewing stem cell. Such specificity can be accomplished in part by the expression of the appropriate growth factors by the hematopoietic cell stroma. However, another means by which such regulation can occur is by the dephosphorylation of a subset of tyrosine-phosphorylated proteins. One mechanism that would allow for specific dephosphorylation is via PTPs that recognize only a fraction of the tyrosine-phosphorylated proteins in the cell. Thus, the analysis of PTPs expressed by HSCs might further our understanding of the mechanisms by which stem cell self-renewal is attained. We report here a candidate PTP that has some of the features that might be expected for a regulator of stem cell differentiation.
Several aspects of PTP HSCF are consistent with a role in the regulation of aspects of early hematopoietic progenitor cell biology. First, the specific expression of the transcript in very early hematopoietic progenitor cells, together with the downregulation of the message as the cells differentiate, is compatible with a role for this enzyme in physiologic aspects of the less-differentiated stem cell. Importantly, this type of downregulation of FTP transcript levels is not observed with several other Thus, for example, the hematopoietic cell phosphatases FTP IC," PTP PEP," and CD45," a11 of which are expressed in the lin'°CD34hi fraction analyzed here (Table I ) , are also all expressed in various mature populations of hematopoietic cells, in sharp contrast to PTP HSCF, which we show here is not expressed in mature cells differentiated in vitro or in vivo. These data suggest that FTP HSCF is an unusual hematopoietic cell FTPase that appears to function during the early, but not late stages of hematopoietic development. Although little is understood regarding the regulation of genes in very early hematopoietic progenitor cells, the apparently unique expression of this gene predominately in these comparatively undifferentiated cells suggests that novel mechanisms of transcriptional regulation might be used in the control of this IOCUS.'~ In addition, the predominate lack of expression of this FTP in most adult tissues, with the exception of extremely low levels in the lung and the kidney, is also consistent with a role for this enzyme specifically within the hematopoietic progenitor cell compartment, although the expression in these organs suggests that this enzyme may play a role in the physiology of some nonhematopoietic cells. This is in stark contrast to the expression of the related PTP PEP,
For personal use only. on October 31, 2017. by guest www.bloodjournal.org From which is found in the mature lymphoid compartment," and PTP PEST, which is apparently ubiquitously expressed in a number of cell lines and tissues.2' Second, the PTP domain can be thought of as a moderator of cell activation by virtue of its ability to dephosphorylate tyrosine residues. Tyrosine phosphorylation can either upregulate or downregulate the activities of various proteins,' so that the PTP HSCF might activate or inhibit a specific subset of tyrosine-phosphorylated proteins. This type of specific modulation would be expected in a cell that requires a downregulation of differentiation, because it would allow for the control of the phosphotyrosine levels of proteins activated by various growth factors produced by the hematopoietic stroma. Together, these data are compatible with a function for this enzyme in the modulation of development of the stem cell that is induced by the various growth factors produced by the hematopoietic microenvironment.
The hypothesis that PTPs such as PTP HSCF are involved with the maintenance of an undifferentiated state in the HSC suggests possibilities regarding the substrates recognized by this type of PTP. Several of the substrates for the PTPs have been previously characterized. For example, the a PTP, a receptor PTP, has been found to regulate the levels of src tyrosine phosphorylation that results in differentiation of neuronal progenitor cells. Lar and CD45 are apparently involved with the regulation of the tyrosine phosphorylation levels of the insulin receptor.2x.30 From the standpoint of hematopoiesis, the SH2 domain containing PTP 1C phosphatase has been shown to be critically involved with the regulation of myeloid development in the motheaten mouse as well as with the activation state of the EPO Finally, another SH2-containing PTP, PTP ID, has been found to positively regulate the activity of the prolactin receptor.'' These examples, among others, are consistent with a role for cytoplasmically localized PTP domains in the regulation of a variety of cellular processes. However, the nature of the substrates recognized by the rarer nuclear PTP family is unknown. The dual specificity (ie, tyrosine and serineithreonine dephosphorylation) phosphatase encoded by the cdc25 locus is a nuclear enzyme that is critical for the regulation of mitosis.32 In addition, PAC-1, another nuclear localized PTP, appears to be involved with the regulation of the mitogen-activated protein kinases. A recently described dual specificity phosphatase, TYP 1, which is related to the vaccinia virus VH 1 phosphatase, appears to be involved with the regulation of both the ERK and JNK family of mitogenactivated protein kinases." These data suggest that several currently described phosphatases appear to play roles in the regulation of tyrosine-phosphorylated nuclear proteins as well.
Another possible substrate for both the nuclear and cytoplasmic PTP enzymes are the STAT proteins. These transcriptional activators encompass a family of at least 6 different members, all of which are activated by the JAK tyrosine JAK phosphorylation is stimulated by the formation of receptor complexes that are stimulated by the binding of various hematopoietic and other growth factor-like molec u l e~. '~ The phosphorylated STAT proteins then dimerize, migrate to the nucleus, and bind specifically to various DNA elements that regulate the transcription of growth and differentiation gene^.^^,^' Thus, because these transcription factors are linked with the activation of hematopoietic differentiation factors, they provide appealing targets for negative regulation in HSCs. The absolute requirement for tyrosine phosphorylation of these transcriptional activators thus suggests that the novel PTP reported here could regulate STAT activation via dephosphorylation of tyrosine residues. In this manner, the upregulation of genes specific to the differentiated state could be inhibited by the dephosphorylation of one or more activated STAT molecules. This hypothesis is especially appealing in the case of the HSCs. In this case, the activation of the STAT proteins by the binding of various hematopoietic growth and differentiation factors, a state that would induce terminal differentiation, could be downregulated by a stem-cell-specific PTP such as PTP HSCF. If this hypothesis is correct, the manner by which specific STAT dephosphorylation occurs must be investigated. However, it is possible that the proline-, serine-, threonine-rich domain of PTP HSCF might function to bind to only a subset of STATs, a hypothesis that we are currently testing.
Finally, recent data have shown that the related PTP PEST can associate with the ~5 2 " ' and ~6 6 "~' SH2-containing adaptor proteins in a protein kinase C-dependent fashion.'x This association was through an interaction between the Nterminal region of SHC and the carboxy-terminal P-, S-, and T-rich region of the PTP PEST. The fact that this association was enhanced by protein kinase C suggested that serine or threonine phosphorylation might be involved, and a serine in the P-, S-, and T-rich region of PTP PEST i s known to be phosphoylated by protein kinase C." Interestingly, carbachol, an activator of G-protein-coupled signaling, was also able to stimulate this association, suggesting that PTP PEST may be involved with the cross talk between G-coupled and tyrosine kinase pathways. Because of the similarity of PTP HSCF to PTP PEST, it is tempting to speculate that this novel hematopoietic cell PTP may also interact with SHC, and we are currently examining this possibility using the yeast two hybrid system as well as coprecipitation analyses.
In summary, the data reported here suggest that hematopoietic stendprogenitor cells specifically express a PTP that appears to be downregulated as the cells differentiate. The PTP seems to be predominately specific to hematopoietic progenitor cells, suggesting an important role in the development of this cell compartment. However, although these data are potentially important, a number of studies remain to be accomplished. Thus, the possibility that the STATs are substrates for this enzyme; the possible interaction of the enzyme with SHC; the constitutive expression of the enzyme in transfected cells, particularly embryonic stem cells, and in transgenic animals; and the effects of null mutations at this locus in vivo may provide for further insights into the mechanisms by which stem cell self-renewal is regulated by this tyrosine phosphatase. For personal use only. on October 31, 2017. by guest www.bloodjournal.org From
